TheraRadar
Data updated: May 26, 2026

HALCINONIDE

Corticosteroid Hormone Receptor Agonists
Dermatology Approved 2019-08-12

HALCINONIDE is indicated for the treatment of Dermatoses.

Source: FDA Label • ENCUBE
3
Indications
--
Phase 3 Trials
6
Years on Market

Details

Status
Prescription
First Approved
2019-08-12
Routes
TOPICAL
Dosage Forms
SOLUTION, CREAM

Companies

Active Ingredient: HALCINONIDE

HALCINONIDE Approval History

2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2019 to 2024
May 2024 ORIGINAL
Update
Sep 2021 ORIGINAL
Update
Aug 2019 ORIGINAL
Update

What HALCINONIDE Treats

1 indications

HALCINONIDE is approved for 1 conditions since its original approval in 2019. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Dermatoses
Source: FDA Label

HALCINONIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to HALCINONIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ALA-SCALP
HYDROCORTISONE
1 shared
LEGACY PHARMA
Shared indications:
ALCLOMETASONE DIPROPIONATE
ALCLOMETASONE DIPROPIONATE
1 shared
SUN PHARMA CANADA
Shared indications:
AMCINONIDE
AMCINONIDE
1 shared
TARO PHARM INDS
Shared indications:
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

HALCINONIDE FDA Label Details

Indications & Usage

HALCINONIDE is indicated for the treatment of Dermatoses.

Looking for the branded version?

HALOG

Full clinical data, patents, trials, and competitive landscape for halcinonide.

See HALOG

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.